- Home
- ELVN vs TYG Comparison
ELVN vs TYG Comparison
Compare ELVN & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | TYG |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 882.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | TYG |
|---|---|---|
| Price | $25.42 | $43.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 148.0K |
| Earning Date | 11-12-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.19 |
| Revenue | N/A | ★ $18,090,640.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.37 |
| Revenue Growth | N/A | ★ 32.84 |
| 52 Week Low | $13.30 | $33.73 |
| 52 Week High | $29.98 | $48.76 |
Technical Indicators
Market Signals| Indicator | ELVN | TYG |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 65.65 |
| Support Level | $23.25 | $41.27 |
| Resistance Level | $29.98 | $42.07 |
| Average True Range (ATR) | 1.98 | 0.72 |
| MACD | 1.30 | 0.34 |
| Stochastic Oscillator | 70.12 | 96.66 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.